Previous Close | 0.2900 |
Open | 0.2900 |
Bid | 0.0000 |
Ask | 2.9000 |
Strike | 57.50 |
Expire Date | 2024-10-18 |
Day's Range | 0.2900 - 0.2900 |
Contract Range | N/A |
Volume | |
Open Interest | 1 |
Ionis Pharmaceuticals (IONS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Key Insights Ionis Pharmaceuticals' Annual General Meeting to take place on 6th of June Salary of US$960.9k is part of...
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced positive results from the Phase 3 OASIS-HAE and OASISplus studies of donidalorsen in patients with hereditary angioedema (HAE) demonstrating significant and sustained reduction in mean monthly HAE attack rates and continued attack rate improvement of >90% with one year of treatment for both monthly or every two-month dosing. Patients who switched to donidalorsen from prior prophylactic treatment also showed 62% further reduction in mean